Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

SANDY TING LIU

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1174808224
CMS profile
1381878
Location
ENCINO, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$77,019.02

124 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Paying entityAmountRecords
Exelixis Inc. $24,716.73 36
Seagen Inc. $19,430.07 30
EMD Serono, Inc. $13,118.58 16
Eisai Inc. $9,493.18 11
PFIZER INC. $4,435.00 2
E.R. Squibb & Sons, L.L.C. $1,729.00 2
AstraZeneca Pharmaceuticals LP $1,387.50 1
Janssen Scientific Affairs, LLC $1,258.97 3
Astellas Pharma US Inc $634.41 5
Lilly USA, LLC $208.11 3
Aveo Pharmaceuticals, Inc. $167.97 1
AbbVie Inc. $145.23 7
Incyte Corporation $125.00 1
Janssen Biotech, Inc. $93.87 2
Myovant Sciences Inc. $40.75 2
SUN PHARMACEUTICAL INDUSTRIES INC. $22.97 1
Astellas Pharma Global Development $11.68 1

Page 3 of 3; records 101–124 of 124 matching records. This page contains 24 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

SANDY TING LIU

NPI 1174808224 · CMS profile ID 1381878

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

ENCINO, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–124 of 124 matching records. This page contains 24 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1174808224?year=2021&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
SANDY TING LIU, NPI 1174808224, CMS profile ID 1381878. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–124 of 124 matching records. This page contains 24 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1174808224?year=2021&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). SANDY TING LIU, NPI 1174808224, CMS profile ID 1381878. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–124 of 124 matching records. This page contains 24 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1174808224?year=2021&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
SANDY TING LIU, NPI 1174808224, CMS profile ID 1381878, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–124 of 124 matching records. This page contains 24 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1174808224?year=2021&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

124 matching records · $77,019.02 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 124 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–124 of 124.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Myovant Sciences Inc. $15.1806/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834966085 CMS
AstraZeneca Pharmaceuticals LP $1,387.5006/17/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829897457 CMS
Seagen Inc. $1,635.0006/17/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832175173 CMS
Janssen Biotech, Inc. $90.0005/28/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 787958763 CMS
EMD Serono, Inc. $1,020.0005/17/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 849180807 CMS
Exelixis Inc. $13.8804/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838868369 CMS
Eisai Inc. $1,350.0004/27/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833777441 CMS
Eisai Inc. $1,620.0004/20/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833765887 CMS
Lilly USA, LLC $74.9504/12/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818696539 CMS
AbbVie Inc. $17.2703/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 799383201 CMS
EMD Serono, Inc. $1,020.0003/19/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 849151127 CMS
Astellas Pharma US Inc $60.9903/11/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821425089 CMS
Exelixis Inc. $18.5803/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838867535 CMS
Eisai Inc. $30.0002/26/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833776659 CMS
AbbVie Inc. $22.1002/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795358481 CMS
Eisai Inc. $1,350.0002/18/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833765155 CMS
EMD Serono, Inc. $1,020.0002/09/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 849178889 CMS
Exelixis Inc. $118.4102/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838867489 CMS
Astellas Pharma US Inc $2.9902/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821425077 CMS
Astellas Pharma US Inc $0.9102/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821425081 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $22.9702/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 851926723 CMS
Exelixis Inc. $21.6902/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838865991 CMS
AbbVie Inc. $20.8401/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795358475 CMS
EMD Serono, Inc. $1,020.0001/14/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 849216253 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $34,288.35 73
PY2020 $17,920.42 36
PY2021 $77,019.02 124
PY2022 $58,341.02 100
PY2023 $83,564.80 140
PY2024 $61,417.36 94
PY2025 $64,988.22 95

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2022 Principal investigator $204,244.97 3
PY2021 Principal investigator $627,298.44 15
PY2020 Principal investigator $119,609.17 10

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

3 records in PY2022

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme LLC $19,168.12 12/31/2022 Covered Recipient Teaching Hospital
Ronald Reagan Ucla
A Phase 3, Randomized, Double-blind Trial of Pembrolizumab MK-3475 Plus Enzalutamide Plus ADT Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer mHSPC KEYNOTE-991 No dispute reported 06/30/2026 940411679
Principal investigator 1 Merck Sharp & Dohme LLC $9,545.85 12/31/2022 Covered Recipient Teaching Hospital
Ronald Reagan Ucla
A Phase 3, Randomized, Double-blind Trial of Pembrolizumab MK-3475 Plus Enzalutamide Plus ADT Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer mHSPC KEYNOTE-991 No dispute reported 06/30/2026 940411681
Principal investigator 2 Merck Sharp & Dohme LLC $175,531.00 09/07/2022 Covered Recipient Teaching Hospital
Ronald Reagan Ucla
An Open-label, Randomized, Phase 3 Study of MK-6482 in Combination with Lenvatinib MK-7902 vs Cabozantinib for Treatment in Participants with Advanced Renal Cell Carcinoma Who Have Progressed After Prior Anti-PD-1,L1 Therapy No dispute reported 06/30/2026 940416837